Skip to main content
Premium Trial:

Request an Annual Quote

Sorenson Forensics Awarded Contract to Assist Forensic DNA Lab in Senegal

NEW YORK (GenomeWeb News) – Sorenson Forensics will help develop DNA forensics capabilities at a research institute in Senegal’s capital of Dakar, the Salt Lake City-based company said today.
Under the agreement with the Senegalese government, Sorenson Forensics will work to help the Center for Diagnostics and Research in Molecular Medicine become the first forensic DNA lab in western Africa, and will provide ongoing support and lab validation services.
Sorenson Forensics said it is currently training two groups of scientists from Senegal at its labs in Salt Lake City. Sorenson representatives will spend a total of five months in Dakar helping to establish lab processes and procedures, and then will provide support over the following year.
"It is critical that these dedicated Senegalese scientists have the tools and processes they need to effectively assist law enforcement and government officials because there is a face and a name behind every forensics case authorities are called to investigate, and a family waiting to hear their results,” Sorenson Forensics’ lab director, Tim Kupferschmid, said in a statement.
Financial terms of the agreement were not released.

The Scan

Study Tracks Off-Target Gene Edits Linked to Epigenetic Features

Using machine learning, researchers characterize in BMC Genomics the potential off-target effects of 19 computed or experimentally determined epigenetic features during CRISPR-Cas9 editing.

Coronary Artery Disease Risk Loci, Candidate Genes Identified in GWAS Meta-Analysis

A GWAS in Nature Genetics of nearly 1.4 million coronary artery disease cases and controls focused in on more than 200 candidate causal genes, including the cell motility-related myosin gene MYO9B.

Multiple Sclerosis Contributors Found in Proteome-Wide Association Study

With a combination of genome-wide association and brain proteome data, researchers in the Annals of Clinical and Translational Neurology tracked down dozens of potential multiple sclerosis risk proteins.

Quality Improvement Study Compares Molecular Tumor Boards, Central Consensus Recommendations

With 50 simulated cancer cases, researchers in JAMA Network Open compared molecular tumor board recommendations with central consensus plans at a dozen centers in Japan.